Trial intelligence / Profile preview

Nesiritide for Prevention of Renal Insufficiency Post Cardiac Surgery

NCT00252200Phase 2Completed

Sponsor
Mayo Clinic
Start
Mar 2003
Primary completion
Oct 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of nesiritide in acute kidney injury (AKI), sponsored by Mayo Clinic. Started Mar 2003; status: completed.

02

Drugs

nesiritide
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT00252200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00252200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call